PHCentral RSS - rss FIRE feed Tue, 3 Mar 2015 11:03:22 GMT Why Heart Rate Matters March 2, 2015 ≥19% INCREASE in the risk of all-cause mortality in patients with left ventricular dysfunction (LVEF ≤ 40%)
≥25% INCREASE in the risk of the composite outcome of CV death or hospital stay for worsening HF in patients with left ventricular dysfunction (LVEF ≤ 40%)]]>
Role for Telomerase in Pulmonary Hypertension March 1, 2015 SteadyMed Raises $12.2M to Advance PAH Therapy March 1, 2015 CDC Says Influenza Vaccine Only 18% Effective This Year February 28, 2015 Adempas Approved in Japan for the Treatment of Pulmonary Arterial Hypertension February 28, 2015 Pregnancy in PAH Patients Focus of Recent Study February 26, 2015 PH Patients Given Higher Lung Transplant Priority with Revised LAS February 25, 2015 Ultrasound-accelerated thrombolysis may improve pulmonary embolism outcomes February 24, 2015 CTEPH Patients Are More Accurately Assessed During Exercise, Study Shows February 23, 2015 Treating pulmonary hypertension in pediatrics. February 22, 2015 Ongoing Clinical Trial: Efficacy of Bosentan in Exercise-Induced PAH Secondary to Congenital Heart Disease February 22, 2015 Up-regulation of Hexokinase1 in the Right Ventricle of Monocrotaline Induced Pulmonary Hypertension February 21, 2015 Radionuclide angiography-assessed RVEF predicts PAH outcomes February 21, 2015 Recent IPF Study Addresses Emotional and Physical Impact on Both Patients and Caregivers February 20, 2015 Right Ventricular Remodeling Might be Adaptative in Idiopathic Pulmonary Arterial Hypertension February 19, 2015 Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension February 18, 2015 The Lasting Legacy of Fen-Phen February 17, 2015 ]]> Researchers Study PAH in Rheumatoid Arthritis Versus Idiopathic PAH February 16, 2015 Smoking is even MORE dangerous than we thought February 16, 2015 ]]> Bosentan Improves Pulmonary Hypertension Secondary to IPF in Individual Case Study February 15, 2015 Native T1 myocardial tissue characterisation in patients with pulmonary hypertension: findings from International T1 Multicentre Study February 15, 2015 EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-?1 signaling February 14, 2015 Pulmonary Arterial Hypertension Could Improve with Calorie Restriction February 14, 2015 Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension February 13, 2015 Survival in rheumatoid arthritis-associated pulmonary arterial hypertension February 12, 2015
Compared with IPAH patients, RA-PAH patients have an older age of onset and lower baseline mPAP. RA-PAH patients have comparable survival to IPAH patients.]]>
Suppression of the TRPC1 Gene Could Prevent Hypoxia-induced Pulmonary Hypertension February 11, 2015 Findings from this study confirmed that RVSP and the expressions of TRPCs were significantly enhanced in a murine model of hypoxia-induced PAH and were markedly suppressed after siRNA-TRPC1 treatment. The authors’ concluded that these findings may offer a therapeutic option for the treatment of patients with PAH refractory to conventional regimens.]]> ERS Pulmonary Hypertension Research Award February 10, 2015 Overview of pulmonary hypertension in adults February 9, 2015 ]]> Increasing Number of Promising PAH Drug Targets Are On the Horizon, According to Study February 9, 2015 West Michigan woman first in world to get life-saving heart device February 8, 2015 SteadyMed Raises $12.2 Million To Advance PAH Therapy February 8, 2015 Bellerophon Therapeutics (BLPH) Plans to Raise $60 Million in February 13th IPO February 7, 2015 Networks Reveal the Connections of Disease February 7, 2015 Researchers Find That Physical Examination is Unreliable in Detecting Pulmonary Hypertension February 6, 2015 Survival advantages of excess body mass index in patients with idiopathic pulmonary arterial hypertension. February 5, 2015
The Kaplan-Meier survival curves for the three BMI categories demonstrated that the overweight and obese group had a significantly higher survival rate than the normal weight and underweight groups (log-rank test, P = 0.027, P = 0.000, respectively). In a stepwise forward regression, lower BMI, higher WHO functional class, lower cardiac index, smaller LVEDDs and absence of targeted medication remained independent predictors of mortality.]]>
New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. February 4, 2015 SSc-PH May Show Increase in Damaged Blood Vessel Biomarker EMPs February 3, 2015 Germany: Interview with a patient suffering from pulmonary arterial hypertension 2/TOC separate articles/Sommer patient interview.pdf February 3, 2015 Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats. February 2, 2015